Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€114.72

€114.72

0.470%
0.54
0.470%
€127.60
 
14:33 / Tradegate WKN: 850103 / Symbol: ABT / Name: Abbott / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Abbott Laboratories is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Abbott

sharewise wants to provide you with the best news and tools for Abbott, so we directly link to the best financial data sources.

News

Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield: https://www.marketbeat.com/logos/articles/med_20250717083934_chart-abt-7172025.png
Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield

If you wonder whether Abbott Laboratories (NYSE: ABT) is a good buy in Q2 2025, the answer is yes. The company’s management, portfolio, cash flow, capital return, and pipeline are why. The stock

Tariff-Resistant Abbott Laboratories on Track for New Highs
Tariff-Resistant Abbott Laboratories on Track for New Highs

Abbott Laboratories (NYSE: ABT) is not immune to the impact of tariffs on its medical device business. However, the company’s diversified business is tariff-resistant, and moves are being made to

Don't Overlook These 2 Dividend Kings in Today's Volatile Market: https://g.foolcdn.com/editorial/images/833943/person-drinking-bottled-drink-with-a-straw.jpg
Don't Overlook These 2 Dividend Kings in Today's Volatile Market

President Donald Trump's trade policies have introduced plenty of volatility to the stock market this year. Steeper tariffs could impact consumer spending and the broader economy in ways that could

GBTG Q2 2025 Earnings Call Transcript
GBTG Q2 2025 Earnings Call Transcript

Image source: The Motley Fool.

Tuesday, Aug. 5, 2025 at 1:00 p.m. ET

Chief Executive Officer — Paul Abbott

Continue reading

Source Fool.com

Abbott Reports 10.5% EPS Growth for Fiscal Q2
Abbott Reports 10.5% EPS Growth for Fiscal Q2

Abbott Laboratories (NYSE:ABT), a global healthcare company known for its medical devices, diagnostics, nutrition, and pharmaceuticals, reported fiscal 2025 earnings on Thursday, July 17, that

Abbott (ABT) Q2 2025 Earnings Call Transcript
Abbott (ABT) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool.

Need a quote from one of our analysts? Email [email protected]

Abbott Laboratories (NYSE:ABT) presented a quarter marked by distinct segment divergence, with medical devices

2 Dividend Stocks to Buy With $500 and Hold Forever
2 Dividend Stocks to Buy With $500 and Hold Forever

Broader equities have been volatile this year, but that's par for the course. The fact that the stock market will sometimes go through erratic periods is not a good reason not to invest. However

2 Stocks, 2 Decades, $200. Is This the Long-Term Dividend Play for Your Portfolio?
2 Stocks, 2 Decades, $200. Is This the Long-Term Dividend Play for Your Portfolio?

Investing in excellent dividend stocks can be a great strategy to mitigate risk and boost long-term returns. Companies that can dispense regular payouts to their shareholders -- especially those

3 Dividend Stocks to Buy and Hold for the Next Decade
3 Dividend Stocks to Buy and Hold for the Next Decade

Many income investors would love to have a low-maintenance portfolio that doesn't require constant attention. They'd prefer to buy great stocks and rake in the dividends without any hiccups.

Three